JSM 2015 Preliminary Program

Online Program Home
My Program

Abstract Details

Activity Number: 56
Type: Invited
Date/Time: Sunday, August 9, 2015 : 4:00 PM to 5:50 PM
Sponsor: CHANCE
Abstract #314624 View Presentation
Title: Changing the TB Drug Development Paradigm: Contributions of Statistical Science
Author(s): Lori Dodd*
Companies: NIAID/NIH
Keywords: adaptive designs ; multi-arm, multi-stage designs ; clinical trials ; image processing ; phase 2 studies ; tuberculosis
Abstract:

Tuberculosis remains a serious global health problem, afflicting an estimated 9 million people in 2013 and causing approximately 1.5 million deaths. Better regimens requiring shorter treatment durations are critically needed to curb this pandemic. The drug pipeline is now producing candidate therapies, after a 30-year period of quiescence. The standard clinical trials paradigm, however, is widely viewed as being too slow to address the crisis. Statistical science has the potential to improve the speed of drug development, through design of more informative and efficient phase 2 and 3 trials. In this talk, I will describe the needs from the perspective of a clinical trialist and propose solutions provided from the field of statistics. Statistical contributions are wide ranging and include high-dimensional image processing to provide better phase 2 endpoints, novel study designs to guide more rational combinations of drugs, and sensibly adaptive study designs.


Authors who are presenting talks have a * after their name.

Back to the full JSM 2015 program





For program information, contact the JSM Registration Department or phone (888) 231-3473.

For Professional Development information, contact the Education Department.

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

2015 JSM Online Program Home